Linda Burns, MD
Request Appointment
Blood and Marrow Transplant Clinic
Phillips-Wangensteen Building
Fifth Floor, Clinic 5B
516 Delaware St. SE
Minneapolis, MN 55455

Philosophy of Care:

My clinical practice area is treatment of malignant and nonmalignant hematologic disorders including lymphoma, leukemia, multiple myeloma, myelodysplasia, aplastic anemia and BMT.

Medical Title:


Clinical Interests:

Languages Spoken:


Board Certifications:

Research Interests:

Majhail NS, Lazarus HM, Burns LJ. A prospective study of iron-overload management in allogeneic hematopoietic transplant survivors. Biol Blood Marrow Transplant. 16(6):832-7, 2010.

McAvoy S, Baker KS, Mulrooney D, Blaes A, Arora M, Burns LJ, Majhail NS. Corticosteroid dose as a risk-factor for avascular necrosis of the bone after hematopoietic-cell transplantation. Biol Blood Marrow Transplant.16(9):1231-6, 2010.

Majhail NS, Challa TR, Mulrooney DA, Baker KS, Burns LJ. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 43(12):949-51, 2009.

Majhail NS, Flowers ME, Ness KK, Jagasia M, Carpenter PA, Arora M, Arai S, Johnston L, Martin PJ, Baker KS, Lee SJ, Burns LJ. High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 43:49-54, 2009.

Majhail NS, Defor TE, Lazarus HM, Burns LJ. Iron-overload after autologous hematopoietic cell transplantation. Leuk Res, 33(4):578-9, 2009.

Kumar P, Defor TE, Brunstein C, Barker JN, Wagner JE, Weisdorf DJ, Burns LJ. Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival. Biol Blood Marrow Transplant.14:1394-400, 2008.

Vallera DA, Sicheneder AR, Taras EP, Brechbiel MW, Vallera JA, Panoskaltsis-Mortari A, Burns LJ. Radiotherapy of CD45 expressing Daudi tumors in nude mice with yttrium-90-labeled, PEGylated anti-CD45 antibody. Cancer Biother and Radiopharm. 22:488-500, 2007.

Majhail NS, Weisdorf DJ, Wagner JE, Defor TE, Brunstein CG, Burns LJ. Comparable results of umbilical cord blood and HLA matched sibling donor hematopoietic stem cell transplant after reduced-intensity preparative regimen for advanced Hodgkin’s lymphoma. Blood. 1;107:3804-7, 2006.

Burns LJ, Weisdorf DJ, DeFor TE, Vesole DH, Repka TL, Blazar BR, Burger SR, Panoskaltsis-Mortari A, Keever-Taylor CA, Zhang MJ, Miller JS. IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial. Bone Marrow Transplant. 32:177-86, 2003.

Burns LJ, Weisdorf DJ, DeFor TE, Repka TL, Ogle KM, Hammer C, Miller JS. Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with IL-2 plus G-CSF in patients with advanced breast cancer. Exp Hematol. 28(1): 96-103, 2000.


Related Health Topics Here

 Visit Other Fairview Sites 
(c) 2012 Fairview Health Services. All rights reserved.